{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:26:25Z","timestamp":1790771185071,"version":"4.1.0"},"reference-count":141,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["725563"],"award-info":[{"award-number":["725563"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["TCP15021"],"award-info":[{"award-number":["TCP15021"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["EP 3083959"],"award-info":[{"award-number":["EP 3083959"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["JP 6490077"],"award-info":[{"award-number":["JP 6490077"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["US 9,822,368"],"award-info":[{"award-number":["US 9,822,368"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["WO 2018\/189225"],"award-info":[{"award-number":["WO 2018\/189225"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.tips.2021.09.005","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T18:38:41Z","timestamp":1633372721000},"page":"1009-1034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Pharmacological tools to target NKCC1 in brain disorders"],"prefix":"10.1016","volume":"42","author":[{"given":"Annalisa","family":"Savardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Borgogno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"De Vivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cancedda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2021.09.005_bb0005","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3389\/fncel.2015.00371","article-title":"Development and regulation of chloride homeostasis in the central nervous system","volume":"9","author":"Watanabe","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tips.2021.09.005_bb0010","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrn3819","article-title":"Cation-chloride cotransporters in neuronal development, plasticity and disease","volume":"15","author":"Kaila","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tips.2021.09.005_bb0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neubiorev.2021.01.024","article-title":"The postnatal GABA shift: a developmental perspective","volume":"124","author":"Peerboom","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.tips.2021.09.005_bb0020","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neubiorev.2018.05.001","article-title":"Chloride transporters and GABA polarity in developmental, neurological and psychiatric conditions","volume":"90","author":"Schulte","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.tips.2021.09.005_bb0025","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tins.2017.07.001","article-title":"NKCC1 chloride importer antagonists attenuate many neurological and psychiatric disorders","volume":"40","author":"Ben-Ari","year":"2017","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tips.2021.09.005_bb0030","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fnins.2019.00310","article-title":"Off-label use of bumetanide for brain disorders: an overview","volume":"13","author":"Kharod","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tips.2021.09.005_bb0035","series-title":"Bumetanide","author":"Sidhu","year":"2021"},{"key":"10.1016\/j.tips.2021.09.005_bb0040","article-title":"Depolarizing GABAA current in the prefrontal cortex is linked with cognitive impairment in a mouse model relevant for schizophrenia","volume":"7","author":"Kim","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tips.2021.09.005_bb0045","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/mds.27651","article-title":"Enhanced Na(+) -K(+) -2Cl(-) cotransporter 1 underlies motor dysfunction in huntington's disease","volume":"34","author":"Hsu","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tips.2021.09.005_bb0050","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1016\/j.ymthe.2021.05.023","article-title":"Restoring neuronal chloride homeostasis with anti-NKCC1 gene therapy rescues cognitive deficits in a mouse model of Down syndrome","volume":"29","author":"Parrini","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tips.2021.09.005_bb0055","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/jcp.27033","article-title":"NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways","volume":"234","author":"Ma","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.tips.2021.09.005_bb0060","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.8787","article-title":"NKCC1 involvement in the epithelial-to-mesenchymal transition is a prognostic biomarker in gliomas","volume":"8","author":"Sun","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.tips.2021.09.005_bb0065","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5607\/en.2017.26.3.122","article-title":"Altered GABAergic signaling in brain disease at various stages of life","volume":"26","author":"Kim","year":"2017","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.tips.2021.09.005_bb0070","first-page":"355","article-title":"Paradoxical reactions elicited by diazepam in children with classic autism","volume":"2","author":"Marrosu","year":"1987","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.tips.2021.09.005_bb0075","first-page":"455","article-title":"Pharmacologic management of agitation and aggression in a pediatric emergency department - a retrospective cohort study","volume":"23","author":"Kendrick","year":"2018","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"10.1016\/j.tips.2021.09.005_bb0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-019-0138-4","article-title":"Autism spectrum disorder","volume":"6","author":"Lord","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.tips.2021.09.005_bb0085","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1126\/science.1247190","article-title":"Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring","volume":"343","author":"Tyzio","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.tips.2021.09.005_bb0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainres.2017.06.018","article-title":"Reduced protein expressions of cytomembrane GABAARbeta3 at different postnatal developmental stages of rats exposed prenatally to valproic acid","volume":"1671","author":"Li","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.tips.2021.09.005_bb0095","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.chempr.2020.06.017","article-title":"Discovery of a small molecule drug candidate for selective NKCC1 inhibition in brain disorders","volume":"6","author":"Savardi","year":"2020","journal-title":"Chem"},{"key":"10.1016\/j.tips.2021.09.005_bb0100","doi-asserted-by":"crossref","first-page":"E7287","DOI":"10.1073\/pnas.1615330113","article-title":"Jointly reduced inhibition and excitation underlies circuit-wide changes in cortical processing in Rett syndrome","volume":"113","author":"Banerjee","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2021.09.005_bb0105","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1523\/JNEUROSCI.4447-13.2014","article-title":"The developmental switch in GABA polarity is delayed in fragile X mice","volume":"34","author":"He","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2021.09.005_bb0110","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1126\/science.1256009","article-title":"Response to comment on \u2018Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring\u2019","volume":"346","author":"Eftekhari","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.tips.2021.09.005_bb0115","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fnmol.2017.00368","article-title":"Combination therapy in Fragile X syndrome; possibilities and pitfalls illustrated by targeting the mGluR5 and GABA pathway simultaneously","volume":"10","author":"Zeidler","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.tips.2021.09.005_bb0120","doi-asserted-by":"crossref","first-page":"9276","DOI":"10.1038\/s41598-019-45635-9","article-title":"Early alterations in a mouse model of Rett syndrome: the GABA developmental shift is abolished at birth","volume":"9","author":"Lozovaya","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2021.09.005_bb0125","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s40478-019-0852-x","article-title":"KCC2 expression levels are reduced in post mortem brain tissue of Rett syndrome patients","volume":"7","author":"Hinz","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tips.2021.09.005_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068851","article-title":"Abnormal expression of cerebrospinal fluid cation chloride cotransporters in patients with Rett syndrome","volume":"8","author":"Duarte","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tips.2021.09.005_bb0135","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1073\/pnas.1524013113","article-title":"KCC2 rescues functional deficits in human neurons derived from patients with Rett syndrome","volume":"113","author":"Tang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2021.09.005_bb0140","doi-asserted-by":"crossref","first-page":"15752","DOI":"10.1038\/s41598-017-15793-9","article-title":"Developmental excitatory-to-inhibitory GABA-polarity switch is disrupted in 22q11.2 deletion syndrome: a potential target for clinical therapeutics","volume":"7","author":"Amin","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2021.09.005_bb0145","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ana.22696","article-title":"Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia","volume":"71","author":"Talos","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2021.09.005_bb0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nbd.2016.07.014","article-title":"Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions","volume":"95","author":"Ruffolo","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tips.2021.09.005_bb0155","first-page":"971","article-title":"Bumetanide in the management of autism. Tunisian experience in Razi Hospital","volume":"97","author":"Hajri","year":"2019","journal-title":"La Tunis. Med."},{"key":"10.1016\/j.tips.2021.09.005_bb0160","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jaac.2020.07.888","article-title":"Bumetanide for Core Symptoms of Autism Spectrum Disorder (BAMBI): a single center, double-blinded, participant-randomized, placebo-controlled, phase two, superiority trial","volume":"60","author":"Sprengers","year":"2021","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.tips.2021.09.005_bb0165","article-title":"Successive clinical application of vitamin D and bumetanide in children with autism spectrum disorder: a case report","volume":"99","author":"Feng","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.tips.2021.09.005_bb0170","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/apa.15747","article-title":"Using bumetanide to treat autism appears promising but further clinical trials are needed to confirm this approach","volume":"110","author":"Ben-Ari","year":"2021","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.tips.2021.09.005_bb0175","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fneur.2017.00469","article-title":"Bumetanide as a candidate treatment for behavioral problems in tuberous sclerosis complex","volume":"8","author":"Vlaskamp","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.tips.2021.09.005_bb0180","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13229-020-00335-4","article-title":"Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study","volume":"11","author":"van Andel","year":"2020","journal-title":"Mol. Autism"},{"key":"10.1016\/j.tips.2021.09.005_bb0185","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-202092","article-title":"The effect of bumetanide treatment on the sensory behaviours of a young girl with Asperger syndrome","volume":"2014","author":"Grandgeorge","year":"2014","journal-title":"BMJ Case Reports"},{"key":"10.1016\/j.tips.2021.09.005_bb0190","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1007\/s10803-020-04709-8","article-title":"Bumetanide oral liquid formulation for the treatment of children and adolescents with autism spectrum disorder: design of two Phase III studies (SIGN trials)","volume":"51","author":"Crutel","year":"2021","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.tips.2021.09.005_bb0195","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nm.3827","article-title":"Reversing excitatory GABAAR signaling restores synaptic plasticity and memory in a mouse model of Down syndrome","volume":"21","author":"Deidda","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2021.09.005_bb0200","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fgene.2017.00028","article-title":"Dysbindin deficiency modifies the expression of GABA neuron and ion permeation transcripts in the developing hippocampus","volume":"8","author":"Larimore","year":"2017","journal-title":"Front. Genet."},{"key":"10.1016\/j.tips.2021.09.005_bb0205","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.alcohol.2012.04.003","article-title":"Effects of third trimester-equivalent ethanol exposure on Cl(-) co-transporter expression, network activity, and GABAergic transmission in the CA3 hippocampal region of neonatal rats","volume":"46","author":"Everett","year":"2012","journal-title":"Alcohol"},{"key":"10.1016\/j.tips.2021.09.005_bb0210","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.neuropharm.2008.10.012","article-title":"Modulation of GABAergic and glutamatergic transmission by ethanol in the developing neocortex: an in vitro test of the excessive inhibition hypothesis of fetal alcohol spectrum disorder","volume":"56","author":"Sanderson","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2021.09.005_bb0215","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/adb.12465","article-title":"Increase of KCC2 in hippocampal synaptic plasticity disturbances after perinatal ethanol exposure","volume":"22","author":"Silvestre de Ferron","year":"2017","journal-title":"Addict. Biol."},{"key":"10.1016\/j.tips.2021.09.005_bb0220","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48648","article-title":"The NKCC1 antagonist bumetanide mitigates interneuronopathy associated with ethanol exposure in utero","volume":"8","author":"Skorput","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.tips.2021.09.005_bb0225","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/00048670701213245","article-title":"Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia","volume":"41","author":"Dean","year":"2007","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.tips.2021.09.005_bb0230","doi-asserted-by":"crossref","first-page":"11088","DOI":"10.1523\/JNEUROSCI.1234-11.2011","article-title":"Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical development and schizophrenia","volume":"31","author":"Hyde","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2021.09.005_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123158","article-title":"Decreased chloride channel expression in the dorsolateral prefrontal cortex in schizophrenia","volume":"10","author":"Sullivan","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tips.2021.09.005_bb0240","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1523\/JNEUROSCI.1423-13.2014","article-title":"Characteristics of the cation cotransporter NKCC1 in human brain: alternate transcripts, expression in development, and potential relationships to brain function and schizophrenia","volume":"34","author":"Morita","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2021.09.005_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2020.102520","article-title":"Expression of GSK3beta, PICK1, NEFL, C4, NKCC1 and synaptophysin in peripheral blood mononuclear cells of the first-episode schizophrenia patients","volume":"55","author":"Zhang","year":"2021","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.tips.2021.09.005_bb0250","doi-asserted-by":"crossref","first-page":"11878","DOI":"10.1038\/s41598-017-12183-z","article-title":"Bumetanide treatment during early development rescues maternal separation-induced susceptibility to stress","volume":"7","author":"Hu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2021.09.005_bb0255","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.bbrc.2017.09.143","article-title":"Neonatal maternal separation delays the GABA excitatory-to-inhibitory functional switch by inhibiting KCC2 expression","volume":"493","author":"Furukawa","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tips.2021.09.005_bb0260","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neulet.2018.08.019","article-title":"Effects of combined brief etomidate anesthesia and postnatal stress on amygdala expression of Cl(-) cotransporters and corticotropin-releasing hormone and alcohol intake in adult rats","volume":"685","author":"Yang","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tips.2021.09.005_bb0265","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fnmol.2019.00012","article-title":"Bumetanide prevents brain trauma-induced depressive-like behavior","volume":"12","author":"Goubert","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.tips.2021.09.005_bb0270","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbi.2020.12.010","article-title":"Overexpression of chloride importer NKCC1 contributes to the sensory-affective and sociability phenotype of rats following neonatal maternal separation","volume":"92","author":"Gazzo","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.tips.2021.09.005_bb0275","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bbi.2020.04.004","article-title":"Interleukin-18 from neurons and microglia mediates depressive behaviors in mice with post-stroke depression","volume":"88","author":"Wu","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.tips.2021.09.005_bb0280","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.neures.2007.07.010","article-title":"Changes in the expression of cation-Cl- cotransporters, NKCC1 and KCC2, during cortical malformation induced by neonatal freeze-lesion","volume":"59","author":"Shimizu-Okabe","year":"2007","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.tips.2021.09.005_bb0285","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/cercor\/bhs375","article-title":"Accumulation of GABAergic neurons, causing a focal ambient GABA gradient, and downregulation of KCC2 are induced during microgyrus formation in a mouse model of polymicrogyria","volume":"24","author":"Wang","year":"2014","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.tips.2021.09.005_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113776","article-title":"Pathology-selective antiepileptic effects in the focal freeze-lesion rat model of malformation of cortical development","volume":"343","author":"Ragot","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tips.2021.09.005_bb0295","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3389\/fneur.2019.01407","article-title":"Role of NKCC1 and KCC2 in epilepsy: from expression to function","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.tips.2021.09.005_bb0300","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.1038\/s41598-019-42191-0","article-title":"Delayed maturation of GABAergic signaling in the Scn1a and Scn1b mouse models of Dravet Syndrome","volume":"9","author":"Yuan","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2021.09.005_bb0305","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/epi.14574","article-title":"A novel GABAergic dysfunction in human Dravet syndrome","volume":"59","author":"Ruffolo","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2021.09.005_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107754","article-title":"Functional characterization of novel bumetanide derivatives for epilepsy treatment","volume":"162","author":"Auer","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2021.09.005_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105297","article-title":"Deletion of the Na-K-2Cl cotransporter NKCC1 results in a more severe epileptic phenotype in the intrahippocampal kainate mouse model of temporal lobe epilepsy","volume":"152","author":"Hampel","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tips.2021.09.005_bb0320","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1007\/s00429-015-1122-8","article-title":"Enhanced expression of potassium-chloride cotransporter KCC2 in human temporal lobe epilepsy","volume":"221","author":"Karlocai","year":"2016","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.tips.2021.09.005_bb0325","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/epi.16778","article-title":"Phenobarbital and midazolam suppress neonatal seizures in a noninvasive rat model of birth asphyxia, whereas bumetanide is ineffective","volume":"62","author":"Johne","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2021.09.005_bb0330","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40263-019-00607-5","article-title":"A preliminary study evaluating the safety and efficacy of bumetanide, an NKCC1 inhibitor, in patients with drug-resistant epilepsy","volume":"33","author":"Gharaylou","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.tips.2021.09.005_bb0335","first-page":"920","article-title":"A pilot randomized, controlled, double-blind trial of bumetanide to treat neonatal seizures","volume":"62","author":"Soul","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2021.09.005_bb0340","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuint.2016.02.002","article-title":"Inhibition of Na(+)-K(+)-2Cl(-) Cotransporter-1 attenuates traumatic brain injury-induced neuronal apoptosis via regulation of Erk signaling","volume":"94","author":"Hui","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.tips.2021.09.005_bb0345","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12868-016-0295-2","article-title":"Astaxanthin alleviates cerebral edema by modulating NKCC1 and AQP4 expression after traumatic brain injury in mice","volume":"17","author":"Zhang","year":"2016","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.tips.2021.09.005_bb0350","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/jpi.12344","article-title":"Melatonin attenuates neuronal apoptosis through up-regulation of K(+) -Cl(-) cotransporter KCC2 expression following traumatic brain injury in rats","volume":"61","author":"Wu","year":"2016","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.tips.2021.09.005_bb0355","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s00429-016-1292-z","article-title":"NKCC1 up-regulation contributes to early post-traumatic seizures and increased post-traumatic seizure susceptibility","volume":"222","author":"Wang","year":"2017","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.tips.2021.09.005_bb0360","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/jnc.13920","article-title":"Transient receptor potential vanilloid type 4 channels mediate Na-K-Cl-co-transporter-induced brain edema after traumatic brain injury","volume":"140","author":"Lu","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tips.2021.09.005_bb0365","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1089\/neu.2019.6415","article-title":"Traumatic brain injury temporal proteome guides KCC2-targeted therapy","volume":"36","author":"Lizhnyak","year":"2019","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.tips.2021.09.005_bb0370","doi-asserted-by":"crossref","first-page":"70","DOI":"10.5214\/ans.0972.7531.1118212","article-title":"Emerging role of WNK1 in pathologic central nervous system signaling","volume":"18","author":"Krueger","year":"2011","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.tips.2021.09.005_bb0375","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11064-017-2344-3","article-title":"The role of K(+)-Cl(-)-cotransporter-2 in neuropathic pain","volume":"43","author":"Kitayama","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.tips.2021.09.005_bb0380","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fphys.2018.00006","article-title":"Pretreatment with AQP4 and NKCC1 inhibitors concurrently attenuated spinal cord edema and tissue damage after spinal cord injury in rats","volume":"9","author":"Yan","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.tips.2021.09.005_bb0385","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jpain.2019.05.005","article-title":"Suppression of WNK1-SPAK\/OSR1 attenuates bone cancer pain by regulating NKCC1 and KCC2","volume":"20","author":"Gao","year":"2019","journal-title":"J. Pain"},{"key":"10.1016\/j.tips.2021.09.005_bb0390","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1113\/JP276952","article-title":"Repeated anodal trans-spinal direct current stimulation results in long-term reduction of spasticity in mice with spinal cord injury","volume":"597","author":"Mekhael","year":"2019","journal-title":"J. Physiol."},{"key":"10.1016\/j.tips.2021.09.005_bb0395","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0172-19.2019","article-title":"Removal of the potassium chloride co-transporter from the somatodendritic membrane of axotomized motoneurons is independent of BDNF\/TrkB signaling but is controlled by neuromuscular innervation","volume":"6","author":"Akhter","year":"2019","journal-title":"eNeuro"},{"key":"10.1016\/j.tips.2021.09.005_bb0400","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.resp.2018.12.009","article-title":"Cervical spinal contusion alters Na(+)-K(+)-2Cl- and K(+)-Cl- cation-chloride cotransporter expression in phrenic motor neurons","volume":"261","author":"Allen","year":"2019","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.tips.2021.09.005_bb0405","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3017678","article-title":"Intramuscular injection of adenoassociated virus encoding human neurotrophic factor 3 and exercise intervention contribute to reduce spasms after spinal cord injury","volume":"2019","author":"Chang","year":"2019","journal-title":"Neural Plast."},{"key":"10.1016\/j.tips.2021.09.005_bb0410","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.celrep.2019.06.059","article-title":"Chloride dysregulation through downregulation of KCC2 mediates neuropathic pain in both sexes","volume":"28","author":"Mapplebeck","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2021.09.005_bb0415","doi-asserted-by":"crossref","first-page":"912","DOI":"10.4103\/1673-5374.268904","article-title":"Expression and effect of sodium-potassium-chloride cotransporter on dorsal root ganglion neurons in a rat model of chronic constriction injury","volume":"15","author":"Tan","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.tips.2021.09.005_bb0420","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1089\/neu.2019.6526","article-title":"Rehabilitation decreases spasticity by restoring chloride homeostasis through the brain-derived neurotrophic factor-KCC2 pathway after spinal cord injury","volume":"37","author":"Beverungen","year":"2020","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.tips.2021.09.005_bb0425","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1097\/j.pain.0000000000000926","article-title":"Neuropathic pain after chronic nerve constriction may not correlate with chloride dysregulation in mouse trigeminal nucleus caudalis neurons","volume":"158","author":"Castro","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.tips.2021.09.005_bb0430","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuint.2017.05.020","article-title":"Inhibition of Na(+)-K(+)-2Cl(-) cotransporter attenuates blood-brain-barrier disruption in a mouse model of traumatic brain injury","volume":"111","author":"Zhang","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.tips.2021.09.005_bb0435","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1172\/JCI134793","article-title":"Preventing neuronal edema increases network excitability after traumatic brain injury","volume":"130","author":"Sawant-Pokam","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2021.09.005_bb0440","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1523\/JNEUROSCI.4079-14.2015","article-title":"NKCC1 Activation is required for myelinated sensory neurons regeneration through JNK-dependent pathway","volume":"35","author":"Modol","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2021.09.005_bb0445","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jocn.2020.10.010","article-title":"Preliminary study of analgesic effect of bumetanide on neuropathic pain in patients with spinal cord injury","volume":"81","author":"Zarepour","year":"2020","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.tips.2021.09.005_bb0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210660","article-title":"Failure of bumetanide to improve outcome after intracerebral hemorrhage in rat","volume":"14","author":"Wilkinson","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tips.2021.09.005_bb0455","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1038\/s41467-018-04677-9","article-title":"Cotransporter-mediated water transport underlying cerebrospinal fluid formation","volume":"9","author":"Steffensen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2021.09.005_bb0460","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1177\/0271678X18770844","article-title":"Exacerbated brain edema in a rat streptozotocin model of hyperglycemic ischemic stroke: evidence for involvement of blood-brain barrier Na-K-Cl cotransport and Na\/H exchange","volume":"39","author":"Yuen","year":"2019","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.tips.2021.09.005_bb0465","doi-asserted-by":"crossref","first-page":"C619","DOI":"10.1152\/ajpcell.00177.2019","article-title":"High glucose-induced effects on Na(+)-K(+)-Cl(-) cotransport and Na(+)\/H(+) exchange of blood-brain barrier endothelial cells: involvement of SGK1, PKCbetaII and SPAK\/OSR1","volume":"320","author":"Klug","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.tips.2021.09.005_bb0470","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/diabetes.54.2.510","article-title":"Bumetanide reduces cerebral edema formation in rats with diabetic ketoacidosis","volume":"54","author":"Lam","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2021.09.005_bb0475","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.2337\/db07-1410","article-title":"Cerebral blood flow and cerebral edema in rats with diabetic ketoacidosis","volume":"57","author":"Yuen","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2021.09.005_bb0480","doi-asserted-by":"crossref","first-page":"702","DOI":"10.2337\/db09-0635","article-title":"Cerebral metabolic alterations in rats with diabetic ketoacidosis: effects of treatment with insulin and intravenous fluids and effects of bumetanide","volume":"59","author":"Glaser","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2021.09.005_bb0485","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nm.4361","article-title":"Inflammation-dependent cerebrospinal fluid hypersecretion by the choroid plexus epithelium in posthemorrhagic hydrocephalus","volume":"23","author":"Karimy","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2021.09.005_bb0490","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ebiom.2017.06.020","article-title":"NKCC1 Regulates migration ability of glioblastoma cells by modulation of actin dynamics and interacting with cofilin","volume":"21","author":"Schiapparelli","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tips.2021.09.005_bb0495","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1158\/1535-7163.MCT-19-0910","article-title":"Blockade of cell volume regulatory protein NKCC1 increases TMZ-induced glioma apoptosis and reduces astrogliosis","volume":"19","author":"Luo","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tips.2021.09.005_bb0500","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3389\/fphys.2020.00911","article-title":"Role of NKCC1 activity in glioma K(+) homeostasis and cell growth: new insights with the bumetanide-derivative STS66","volume":"11","author":"Luo","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.tips.2021.09.005_bb0505","doi-asserted-by":"crossref","first-page":"E1618","DOI":"10.1073\/pnas.1716871115","article-title":"Restoring GABAergic inhibition rescues memory deficits in a Huntington's disease mouse model","volume":"115","author":"Dargaei","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2021.09.005_bb0510","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/s41467-018-03802-y","article-title":"GABAergic inhibition in dual-transmission cholinergic and GABAergic striatal interneurons is abolished in Parkinson disease","volume":"9","author":"Lozovaya","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2021.09.005_bb0515","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/WNF.0000000000000114","article-title":"Bumetanide to treat Parkinson disease: a report of 4 cases","volume":"39","author":"Damier","year":"2016","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.tips.2021.09.005_bb0520","first-page":"207","article-title":"Bumetanide to treat Parkinson's disease patients suffering from freezing of gait resistant to both dopamine replacement treatment and STN DBS: an open-label pilot study (BUMFOG)","volume":"405","author":"Elsayed","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.tips.2021.09.005_bb0525","article-title":"Efficacy and safety of bumetanide in patients with amyotrophic lateral sclerosis: a randomized controlled clinical trial","author":"Mehrabi","year":"2021","journal-title":"Res. Square"},{"key":"10.1016\/j.tips.2021.09.005_bb0530","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41398-020-01027-6","article-title":"Environmental regulation of the chloride transporter KCC2: switching inflammation off to switch the GABA on?","volume":"10","author":"Pozzi","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.tips.2021.09.005_bb0535","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nn.3890","article-title":"Early depolarizing GABA controls critical-period plasticity in the rat visual cortex","volume":"18","author":"Deidda","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2021.09.005_bb0540","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.124","article-title":"A randomised controlled trial of bumetanide in the treatment of autism in children","volume":"2","author":"Lemonnier","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.tips.2021.09.005_bb0545","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2165\/00003495-198428050-00003","article-title":"Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use","volume":"28","author":"Ward","year":"1984","journal-title":"Drugs"},{"key":"10.1016\/j.tips.2021.09.005_bb0550","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuropharm.2012.05.045","article-title":"Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments","volume":"69","author":"Loscher","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2021.09.005_bb0555","first-page":"808","article-title":"Diagnosing acute interstitial nephritis: considerations for clinicians","volume":"12","author":"Nussbaum","year":"2019","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.tips.2021.09.005_bb0560","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1177\/002215549704500601","article-title":"Immunohistochemical localization of the Na-K-Cl co-transporter (NKCC1) in the gerbil inner ear","volume":"45","author":"Crouch","year":"1997","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.tips.2021.09.005_bb0565","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/9713","article-title":"Deafness and imbalance associated with inactivation of the secretory Na-K-2Cl co-transporter","volume":"22","author":"Delpire","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2021.09.005_bb0570","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1073\/pnas.090091297","article-title":"Uncompensated polyuria in a mouse model of Bartter's syndrome","volume":"97","author":"Takahashi","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2021.09.005_bb0575","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fncel.2016.00090","article-title":"Failure of the Nemo trial: bumetanide is a promising agent to treat many brain disorders but not newborn seizures","volume":"10","author":"Ben-Ari","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tips.2021.09.005_bb0580","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1523\/JNEUROSCI.4121-14.2015","article-title":"Osmoregulation requires brain expression of the renal Na-K-2Cl cotransporter NKCC2","volume":"35","author":"Konopacka","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2021.09.005_bb0585","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2017.02.006","article-title":"Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain","volume":"117","author":"Romermann","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2021.09.005_bb0590","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuroscience.2014.11.031","article-title":"In vivo effects of bumetanide at brain concentrations incompatible with NKCC1 inhibition on newborn DGC structure and spontaneous EEG seizures following hypoxia-induced neonatal seizures","volume":"286","author":"Wang","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2021.09.005_bb0595","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.conb.2016.11.012","article-title":"Neuronal chloride and excitability - the big impact of small changes","volume":"43","author":"Raimondo","year":"2017","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.tips.2021.09.005_bb0600","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1517\/13543776.2013.780598","article-title":"Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 - 2013)","volume":"23","author":"Carta","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.tips.2021.09.005_bb0605","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00424-020-02425-x","article-title":"Bicarbonate permeation through anion channels: its role in health and disease","volume":"472","author":"Shin","year":"2020","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.tips.2021.09.005_bb0610","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ana.24124","article-title":"A novel prodrug-based strategy to increase effects of bumetanide in epilepsy","volume":"75","author":"Tollner","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2021.09.005_bb0615","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/epi.13346","article-title":"The bumetanide prodrug BUM5, but not bumetanide, potentiates the antiseizure effect of phenobarbital in adult epileptic mice","volume":"57","author":"Erker","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2021.09.005_bb0620","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuropharm.2018.09.025","article-title":"Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy","volume":"143","author":"Brandt","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2021.09.005_bb0625","first-page":"12","article-title":"Structure-activity relationships of aminobenzoic acid diuretics and related compounds","volume":"83","author":"Tvaermose Nielsen","year":"1978","journal-title":"Am. Chem. Soc. Symp. Ser."},{"key":"10.1016\/j.tips.2021.09.005_bb0630","doi-asserted-by":"crossref","first-page":"9877","DOI":"10.1038\/s41598-018-27995-w","article-title":"Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B","volume":"8","author":"Hampel","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2021.09.005_bb0635","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/STROKEAHA.118.024287","article-title":"A Novel Na(+)-K(+)-Cl(-) Cotransporter 1 inhibitor STS66* reduces brain damage in mice after ischemic stroke","volume":"50","author":"Huang","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.tips.2021.09.005_bb0640","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/epi.16912","article-title":"A combination of phenobarbital and the bumetanide derivative bumepamine prevents neonatal seizures and subsequent hippocampal neurodegeneration in a rat model of birth asphyxia","volume":"62","author":"Johne","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2021.09.005_bb0645","doi-asserted-by":"crossref","first-page":"10203","DOI":"10.1021\/acs.jmedchem.1c00603","article-title":"Design, synthesis, in vitro and in vivo characterization of selective NKCC1 inhibitors for the treatment of core symptoms in Down Syndrome","volume":"64","author":"Borgogno","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2021.09.005_bb0650","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1042\/BJ20131478","article-title":"The WNK-regulated SPAK\/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters","volume":"458","author":"de Los Heros","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.tips.2021.09.005_bb0655","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41467-019-13851-6","article-title":"Modulation of brain cation-Cl(-) cotransport via the SPAK kinase inhibitor ZT-1a","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2021.09.005_bb0660","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau0164","article-title":"Pharmacological enhancement of KCC2 gene expression exerts therapeutic effects on human Rett syndrome neurons and Mecp2 mutant mice","volume":"11","author":"Tang","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tips.2021.09.005_bb0665","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.trechm.2021.05.004","article-title":"Cation-coupled chloride cotransporters: chemical insights and disease implications","volume":"3","author":"Portioli","year":"2021","journal-title":"Trends Chem."},{"key":"10.1016\/j.tips.2021.09.005_bb0670","doi-asserted-by":"crossref","first-page":"C324","DOI":"10.1152\/ajpcell.00566.2020","article-title":"Advances in the development of novel compounds targeting cation-chloride cotransporter physiology","volume":"320","author":"Delpire","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.tips.2021.09.005_bb0675","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41398-020-0692-2","article-title":"Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA\/glutamate ratios","volume":"10","author":"Zhang","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.tips.2021.09.005_bb0680","doi-asserted-by":"crossref","first-page":"9195","DOI":"10.1038\/s41598-020-65500-4","article-title":"Measurement of excitation-inhibition ratio in autism spectrum disorder using critical brain dynamics","volume":"10","author":"Bruining","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2021.09.005_bb0685","article-title":"Prediction of behavioral improvement through resting-state EEG and clinical severity in a randomized controlled trial testing bumetanide in autism spectrum disorder","author":"Juarez-Martinez","year":"2021","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.tips.2021.09.005_bb0690","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/1362361313514141","article-title":"Improving emotional face perception in autism with diuretic bumetanide: a proof-of-concept behavioral and functional brain imaging pilot study","volume":"19","author":"Hadjikhani","year":"2015","journal-title":"Autism"},{"key":"10.1016\/j.tips.2021.09.005_bb0695","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1038\/s41598-018-21958-x","article-title":"Bumetanide for autism: more eye contact, less amygdala activation","volume":"8","author":"Hadjikhani","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2021.09.005_bb0700","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/WNR.0000000000001216","article-title":"Brain microstructural abnormalities correlate with KCC2 downregulation in refractory epilepsy","volume":"30","author":"Gharaylou","year":"2019","journal-title":"Neuroreport"},{"key":"10.1016\/j.tips.2021.09.005_bb0705","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3389\/fneur.2019.00483","article-title":"Longitudinal effects of bumetanide on neuro-cognitive functioning in drug-resistant epilepsy","volume":"10","author":"Gharaylou","year":"2019","journal-title":"Front. Neurol."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614721001760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614721001760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T09:11:47Z","timestamp":1759050707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614721001760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":141,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0165614721001760"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2021.09.005","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological tools to target NKCC1 in brain disorders","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2021.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}